Voice of America - January 13, 2004
Joe De Capua
Washington

Click to download/open (MP3)
Click to download/open (Real Audio)

Swiss researchers say HIV/AIDS patients in stable relationships are generally healthier and have a better chance of living longer. They base their findings a study of more than 37-hundred patients in Switzerland who receive anti-retroviral drug therapy.

Researchers admit they can only speculate as to why patients in stable relationships fared so much better. But Dr. Heiner Bucher of the University Hospital in Basel, Switzerland, says the results are clear.

"In terms of outcome, those in stable partnerships were twenty percent less likely to progress to AIDS or death - and forty percent less likely to die from any cause. So I think these are quite impressive figures."

He says patients with HIV who are in stable relationships often have stronger immune systems and lower levels of the AIDS virus in their bodies. Professor Bucher says these patients may be less likely to suffer from depression.

"It’s known from other conditions like coronary heart disease that those with depression have a poorer prognosis. So that’s one possible reason. The other reason I think which is important – where we have indirect evidence – is that I think that patients with stable partners do somewhat better in taking the drugs. There are very complicated drug regimens still today, even though they are becoming better and easier to take."

Because of the study, researchers plan to look into whether other relationships can produce similar results. Such as those with family members or even health care workers.

"To live with HIV is a difficult condition, even today with therapy. And I think there are so many other aspects – you know, the complicated drug regimens that people have to take – that you experience discrimination. So, I think to cope with this difficult condition it’s absolutely necessary that you have a good social network. And that’s why we looked at this question."

Professor Bucher says developing countries won’t be able conduct similar studies until they, too, are able to treat large numbers of patients with the latest drugs. But he says it’s clear there are many other ways to treat a patient in addition to drug therapy.

040113
VA040104

Copyright © 2004 - Voice of America. You are welcome to use any material that is published by voanews.com, or you may link to any of the web pages that Voice of America has published on the internet. There is no need to request further permission. Should you wish to establish a link to any VOA web pages, please send your request to pubaff@ibb.gov. We would appreciate that credit for any use of VOA material be given to voanews.com, Voice of America, or VOA, and we ask that you not abridge or edit any VOA material which you may use.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, the National Library of Medicine, Bridgestone Firestone Trust Fund, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .